الحملات
View Allالوثائق
View Allالمركز الإعلامي
View All
SFDA Opens Submissions for the 6th Annual Regulatory Research Day 2026
The Saudi Food and Drug Authority (SFDA) has officially announced the opening of submissions for its sixth annual Regulatory Research Day 2026. The...
SFDA:AI-Powered 'RASID'Service Cuts Controlled Medication Verification Time for Hajj Pilgrims by 98%
The Saudi Food and Drug Authority (SFDA) has activated the Regulatory AI System for Incoming Drugs (RASID) service to support regulatory operations at...
SFDA Grants Orphan Drug Designation to “Gomekli” for the Treatment of Neurofibromatosis Type 1 (NF1)
The Saudi Food and Drug Authority (SFDA) has granted orphan drug designation to Gomekli (mirdametinib), developed by SpringWorks Therapeutics, to...
The SFDA Grants Breakthrough Designation to "ZENBEXUS" for the Treatment of Adult Patients with Mult
The Saudi Food and Drug Authority (SFDA) has granted Breakthrough Designation to ZENBEXUS (Iberdomide), developed by Bristol-Myers Squibb, for the...
SFDA CEO Congratulates the Leadership on the Success of the 1447 AH Hajj Season
The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, extended his congratulations to the Custodian of the Two Holy...
SFDA CEO Extends Congratulations to the Wise Leadership on the Occasion of Eid al-Adha
The CEO of the Saudi Food and Drug Authority (SFDA), H.E. Dr. Hisham S. Aljadhey, extended his warmest congratulations to the Custodian of the Two...
Comments and Suggestions
For any inquiries or comments about the government services, please fill in the required information.